PPAR-γ activation by pioglitazone inhibits microglia-mediated neuroinflammation and alleviates disease in neuromyelitis optica spectrum disorders
Leung Wah Yick, Ethel Yin Ying Chan, Wenying Zou, Krystal Xiwing Yau, Jason Shing Cheong Kwan, Chi Yan Lee, Koon Ho Chan · 2025
Read PPAR-γ activation by pioglitazone inhibits microglia-mediated neuroinflammation and alleviates disease in neuromyelitis optica spectrum disorders by Leung Wah Yick, Ethel Yin Ying Chan, Wenying Zou, Krystal Xiwing Yau, Jason Shing Cheong Kwan, Chi Yan Lee, Koon Ho Chan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729228.txt.
Description
Leung Wah Yick and co-authors test whether a diabetes drug can calm the immune attack in neuromyelitis optica spectrum disorders. Their 2025 study focuses on microglia, brain immune cells that help antibodies injure nerve tissue in this disease. The drug pioglitazone switches on a cell regulator called PPAR-gamma.
In mice given the human disease antibody, the drug eased movement problems and tissue damage. It lowered microglia activity and inflammatory signals, and blocking the regulator erased the benefit. A blood marker of microglia activity rose in both mice and patients, then fell with treatment. The authors propose repurposing this drug class for acute attacks of the disease.
Catalog record
| CREATOR | Leung Wah Yick, Ethel Yin Ying Chan, Wenying Zou, Krystal Xiwing Yau, Jason Shing Cheong Kwan, Chi Yan Lee, Koon Ho Chan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |